NVCR
Price
$14.87
Change
+$0.21 (+1.43%)
Updated
Oct 10 closing price
19 days until earnings call
STAA
Price
$31.19
Change
-$0.35 (-1.11%)
Updated
Oct 10 closing price
19 days until earnings call
Ad is loading...

NVCR vs STAA

Header iconNVCR vs STAA Comparison
Open Charts NVCR vs STAABanner chart's image
NovoCure
Price$14.87
Change+$0.21 (+1.43%)
Volume$827.74K
CapitalizationN/A
STAAR Surgical
Price$31.19
Change-$0.35 (-1.11%)
Volume$706.31K
CapitalizationN/A
View a ticker or compare two or three
NVCR vs STAA Comparison Chart
Loading...
NVCR
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
STAA
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
VS
NVCR vs. STAA commentary
Oct 11, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is NVCR is a StrongSell and STAA is a StrongSell.

COMPARISON
Comparison
Oct 11, 2024
Stock price -- (NVCR: $14.87 vs. STAA: $31.19)
Brand notoriety: NVCR and STAA are both not notable
Both companies represent the Medical Specialties industry
Current volume relative to the 65-day Moving Average: NVCR: 91% vs. STAA: 82%
Market capitalization -- NVCR: $1.66B vs. STAA: $1.91B
NVCR [@Medical Specialties] is valued at $1.66B. STAA’s [@Medical Specialties] market capitalization is $1.91B. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The average market capitalization across the [@Medical Specialties] industry is $7.89B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

NVCR’s FA Score shows that 1 FA rating(s) are green whileSTAA’s FA Score has 1 green FA rating(s).

  • NVCR’s FA Score: 1 green, 4 red.
  • STAA’s FA Score: 1 green, 4 red.
According to our system of comparison, both NVCR and STAA are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

NVCR’s TA Score shows that 3 TA indicator(s) are bullish while STAA’s TA Score has 6 bullish TA indicator(s).

  • NVCR’s TA Score: 3 bullish, 5 bearish.
  • STAA’s TA Score: 6 bullish, 5 bearish.
According to our system of comparison, STAA is a better buy in the short-term than NVCR.

Price Growth

NVCR (@Medical Specialties) experienced а +2.27% price change this week, while STAA (@Medical Specialties) price change was -8.69% for the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was -2.01%. For the same industry, the average monthly price growth was +3.93%, and the average quarterly price growth was -2.96%.

Reported Earning Dates

NVCR is expected to report earnings on Feb 20, 2025.

STAA is expected to report earnings on Feb 19, 2025.

Industries' Descriptions

@Medical Specialties (-2.01% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
STAA($1.91B) has a higher market cap than NVCR($1.66B). STAA YTD gains are higher at: -0.064 vs. NVCR (-0.402). STAA has higher annual earnings (EBITDA): 33.2M vs. NVCR (-177.45M). NVCR has more cash in the bank: 911M vs. STAA (221M). STAA has less debt than NVCR: STAA (35.8M) vs NVCR (596M). NVCR has higher revenues than STAA: NVCR (509M) vs STAA (322M).
NVCRSTAANVCR / STAA
Capitalization1.66B1.91B87%
EBITDA-177.45M33.2M-534%
Gain YTD-0.402-0.064627%
P/E RatioN/A90.79-
Revenue509M322M158%
Total Cash911M221M412%
Total Debt596M35.8M1,665%
FUNDAMENTALS RATINGS
NVCR vs STAA: Fundamental Ratings
NVCR
STAA
OUTLOOK RATING
1..100
6762
VALUATION
overvalued / fair valued / undervalued
1..100
100
Overvalued
83
Overvalued
PROFIT vs RISK RATING
1..100
10097
SMR RATING
1..100
9684
PRICE GROWTH RATING
1..100
6365
P/E GROWTH RATING
1..100
1231
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

STAA's Valuation (83) in the Medical Specialties industry is in the same range as NVCR (100). This means that STAA’s stock grew similarly to NVCR’s over the last 12 months.

STAA's Profit vs Risk Rating (97) in the Medical Specialties industry is in the same range as NVCR (100). This means that STAA’s stock grew similarly to NVCR’s over the last 12 months.

STAA's SMR Rating (84) in the Medical Specialties industry is in the same range as NVCR (96). This means that STAA’s stock grew similarly to NVCR’s over the last 12 months.

NVCR's Price Growth Rating (63) in the Medical Specialties industry is in the same range as STAA (65). This means that NVCR’s stock grew similarly to STAA’s over the last 12 months.

NVCR's P/E Growth Rating (12) in the Medical Specialties industry is in the same range as STAA (31). This means that NVCR’s stock grew similarly to STAA’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
NVCRSTAA
RSI
ODDS (%)
Bullish Trend 2 days ago
73%
Bullish Trend 2 days ago
73%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
69%
Bullish Trend 2 days ago
75%
Momentum
ODDS (%)
Bearish Trend 2 days ago
86%
Bullish Trend 2 days ago
82%
MACD
ODDS (%)
Bearish Trend 2 days ago
84%
Bearish Trend 2 days ago
89%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
86%
Bearish Trend 2 days ago
82%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
85%
Bullish Trend 2 days ago
77%
Advances
ODDS (%)
Bullish Trend 28 days ago
77%
Bullish Trend 14 days ago
77%
Declines
ODDS (%)
Bearish Trend 14 days ago
89%
Bearish Trend 3 days ago
85%
BollingerBands
ODDS (%)
N/A
Bearish Trend 2 days ago
80%
Aroon
ODDS (%)
Bearish Trend 2 days ago
85%
Bullish Trend 2 days ago
76%
View a ticker or compare two or three
Ad is loading...
NVCR
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
STAA
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
GME20.910.41
+2.00%
GameStop Corp
SPY576.13-1.01
-0.18%
SPDR® S&P 500® ETF Trust
AAPL229.04-0.50
-0.22%
Apple
BTC.X60274.500000-307.601560
-0.51%
Bitcoin cryptocurrency
TSLA238.77-2.28
-0.95%
Tesla

NVCR and

Correlation & Price change

A.I.dvisor indicates that over the last year, NVCR has been loosely correlated with MASS. These tickers have moved in lockstep 49% of the time. This A.I.-generated data suggests there is some statistical probability that if NVCR jumps, then MASS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NVCR
1D Price
Change %
NVCR100%
+1.43%
MASS - NVCR
49%
Loosely correlated
-2.06%
GH - NVCR
45%
Loosely correlated
-1.34%
TWST - NVCR
43%
Loosely correlated
+0.48%
KIDS - NVCR
43%
Loosely correlated
-0.98%
VCYT - NVCR
43%
Loosely correlated
+1.10%
More

STAA and

Correlation & Price change

A.I.dvisor indicates that over the last year, STAA has been loosely correlated with XRAY. These tickers have moved in lockstep 53% of the time. This A.I.-generated data suggests there is some statistical probability that if STAA jumps, then XRAY could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To STAA
1D Price
Change %
STAA100%
-1.11%
XRAY - STAA
53%
Loosely correlated
-0.33%
NVST - STAA
47%
Loosely correlated
-1.10%
WST - STAA
44%
Loosely correlated
+1.24%
ALGN - STAA
37%
Loosely correlated
-1.77%
VCYT - STAA
35%
Loosely correlated
+1.10%
More